Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

123.93 +0.11 (+0.09%)
Official Closing Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,448,158
Open 123.41
Bid (Size) 123.55 (100)
Ask (Size) 124.19 (100)
Prev. Close 123.82
Today's Range 122.63 - 124.84
52wk Range 73.31 - 124.19
Shares Outstanding 2,531,374,696
Dividend Yield 2.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Merck to Participate in the TD Cowen 46th Annual Health Care Conference
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck Evolves Human Health Operating Structure to Support Portfolio Execution
From Merck & Co., Inc.
Via Business Wire

Performance

YTD
+16.4%
+16.4%
1 Month
+15.4%
+15.4%
3 Month
+23.4%
+23.4%
6 Month
+45.3%
+45.3%
1 Year
+35.8%
+35.8%

More News

Read More
News headline image
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades ↗
Via The Motley Fool
Topics Intellectual Property
Merck & Co. Inc. (NYSE:MRK) Emerges as a Strong Dividend Contender Through Methodical Screening ↗
Via Chartmill
News headline image
Could Merck Stock Quietly Help Turn Steady Dividends Into a Millionaire Retirement? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
ImmunityBio (IBRX): The Rise of Immunotherapy 2.0 and the Global Expansion of ANKTIVA
Via Finterra
Topics Lawsuit
News headline image
Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
From Merck & Co., Inc. and Mayo Clinic
Via Business Wire
News headline image
Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline
Via Finterra
Topics Economy Intellectual Property
News headline image
Anktiva Vs Keytruda: ImmunityBio Exec Chair Slams FDA For Double Standards In Approvals ↗
Via Stocktwits
News headline image
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
Via MarketMinute
Topics Intellectual Property
News headline image
8 Cheap Stocks to Buy in 2026 ↗
Via The Motley Fool
News headline image
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗
Via The Motley Fool
Topics Stocks
News headline image
Prediction: These Could Be the Best-Performing Value Stocks Through 2030 ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results
Via MarketMinute
Topics Earnings
News headline image
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug? ↗
Via The Motley Fool
News headline image
Dow Jones 267-Point Slide: Blue-Chip Leaders and the AI Reality Check
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
3 Mega-Cap Stocks for Long-Term Investors
Via StockStory
Topics Supply Chain
News headline image
The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
The Bioelectronic Frontier: A Deep-Dive into NovoCure’s Multi-Indication Transformation
Via Finterra
Topics Initial Public Offering Intellectual Property
News headline image
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
From Merck & Co., Inc.
Via Business Wire
News headline image
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 123.93
When was Merck & Co last traded?
The last trade of Merck & Co was at 02/24/26 04:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 313.71B
How many shares of Merck & Co are outstanding?
Merck & Co has 314B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.